Valion Bio Reports Initial Feasibility Evaluation of BioScan-NMR
Valion Bio said Velocity Bioworks completed an initial feasibility evaluation of LarmorBio’s BioScan-NMR, finding NMR signals correlated with OD600 and supporting further development.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Valion Bio Reports Early Results Showing NMR Potential to Track Microbial Growth
Valion Bio's Velocity Bioworks subsidiary completed an initial feasibility evaluation of LarmorBio's BioScan-NMR platform for biologics manufacturing. Testing showed a strong correlation between nuclear magnetic resonance signals and optical density at 600 nm, a measure of cell density. The early-stage proof of concept